Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.Int J Mol Sci. 2019 Feb 01; 20(3)IJ
Abstract
Matrix Gla Protein (MGP), a small Gla vitamin K-dependent protein, is the most powerful natural occurring inhibitor of calcification in the human body. To become biologically active, MGP must undergo vitamin K-dependent carboxylation and phosphorylation. Vitamin K deficiency leads to the inactive uncarboxylated, dephosphorylated form of MGP (dpucMGP). We aimed to review the existing data on the association between circulating dpucMGP and vascular calcification, renal function, mortality, and cardiovascular disease in distinct populations. Moreover, the association between vitamin K supplementation and serum levels of dpucMGP was also reviewed.
Links
MeSH
Biological TransportCalcium-Binding ProteinsCardiovascular DiseasesDietary SupplementsExtracellular Matrix ProteinsGene Expression RegulationHumansPhosphorylationProtein Processing, Post-TranslationalRenal Insufficiency, ChronicSurvival AnalysisVascular CalcificationVascular StiffnessVitamin KVitamin K Deficiency
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
30717170
Clinical Trial Links
Citation
Roumeliotis, Stefanos, et al. "Association of the Inactive Circulating Matrix Gla Protein With Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: a Review." International Journal of Molecular Sciences, vol. 20, no. 3, 2019.
Roumeliotis S, Dounousi E, Eleftheriadis T, et al. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Int J Mol Sci. 2019;20(3).
Roumeliotis, S., Dounousi, E., Eleftheriadis, T., & Liakopoulos, V. (2019). Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. International Journal of Molecular Sciences, 20(3). https://doi.org/10.3390/ijms20030628
Roumeliotis S, et al. Association of the Inactive Circulating Matrix Gla Protein With Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: a Review. Int J Mol Sci. 2019 Feb 1;20(3) PubMed PMID: 30717170.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.
AU - Roumeliotis,Stefanos,
AU - Dounousi,Evangelia,
AU - Eleftheriadis,Theodoros,
AU - Liakopoulos,Vassilios,
Y1 - 2019/02/01/
PY - 2019/01/05/received
PY - 2019/01/29/revised
PY - 2019/01/30/accepted
PY - 2019/2/6/entrez
PY - 2019/2/6/pubmed
PY - 2019/5/18/medline
KW - calcification
KW - cardiovascular disease
KW - dpucMGP
KW - matrix Gla protein
KW - mortality
KW - renal function
KW - vitamin K.
JF - International journal of molecular sciences
JO - Int J Mol Sci
VL - 20
IS - 3
N2 - Matrix Gla Protein (MGP), a small Gla vitamin K-dependent protein, is the most powerful natural occurring inhibitor of calcification in the human body. To become biologically active, MGP must undergo vitamin K-dependent carboxylation and phosphorylation. Vitamin K deficiency leads to the inactive uncarboxylated, dephosphorylated form of MGP (dpucMGP). We aimed to review the existing data on the association between circulating dpucMGP and vascular calcification, renal function, mortality, and cardiovascular disease in distinct populations. Moreover, the association between vitamin K supplementation and serum levels of dpucMGP was also reviewed.
SN - 1422-0067
UR - https://www.unboundmedicine.com/medline/citation/30717170/Association_of_the_Inactive_Circulating_Matrix_Gla_Protein_with_Vitamin_K_Intake_Calcification_Mortality_and_Cardiovascular_Disease:_A_Review_
DB - PRIME
DP - Unbound Medicine
ER -